NCT02002975View on ClinicalTrials.gov

"Pioglitazone Special Drug Use Surveillance Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"

CompletedOBSERVATIONAL
Enrollment

18,223

Participants

Timeline

Start Date

October 16, 2007

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Pioglitazone

Pioglitazone tablets

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY